New Malaria Drug For Infants Gains Approval In Africa Amid Push To Lower Child Mortality
In a major step toward reducing child mortality, Swiss health authorities have approved the first malaria treatment specifically designed for newborns and infants under 4.5kg. The drug, known as Coartem Baby marketed as Riamet Baby in some countries was developed by pharmaceutical
Follow Us